Tus kws kho mob
QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 20, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2701 - 2710 ntawm 4179
Tus kws kho mob
QP20-17 Searching Eligibility and Benefits
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 08, 2017
Tus kws kho mob
QP68-18 Site of Care Drug Infusion/Injection Program
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP61-18 Availity Authorization Training with Live Demo
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 06, 2018
Tus kws kho mob
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP28-17 Notification of Provider Submitted Appeals
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 12, 2017
Tus kws kho mob
QP60R1-18 Update: Change to Call Center for Transportation for MHCP Members
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP62-18 2018 Fall Blue Cross Basic Seminars to Include Availity Portal Training
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP39-16 Digital Breast Tomosynthesis (DBT) for Routine Breast Cancer Screening
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 15, 2016